Updates

Craneware - Shares spike vertically by over Â£1

October 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The shares soared vertically by 122p to 510p after Craneware announced better-than expected final results. Pretax profit rose 24% to US$7.3m on turnover that increased 23% to US$28.8m, while eps was up from 18 to 22 cents. However, what excited investors was the higher than expected new order intake of US$58m, 34% higher than last year and beating earlier guidance for 25% growth. These annuity based contract wins mean Craneware now has almost US$90m of future revenues booked, providing strong visibility over the next three years. Meanwhile, net cash rose from US$26m to US$29m. Craneware, which supplies billing and auditing software to help US hospitals to improve their financial performance, benefited from a beefed up sales team, ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Prezzo - 11% eps upgrade

Alliance Pharma

Craneware (September 2013)

Craneware (November 2012)

Craneware - Second downgrade this year (August 2012)

Craneware (March 2012)

Craneware (November 2011)

Craneware - New contract wins (September 2011)

Craneware - Acquistion raises forecasts (April 2011)

Craneware - Another amazing share price spike (December 2010)

Craneware (June 2010)

Craneware - Billing software firm enjoying quick-fire growth (February 2010)

Craneware - Billing software firm sees huge US healthcare opportunity (October 2008)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X